Sio Gene Therapies Inc.
SIOX · NASDAQ
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $53,399 | $24,903 | $47,110 | $87,552 |
| G&A Expenses | $18,163 | $17,294 | $22,061 | $39,466 |
| SG&A Expenses | $18,163 | $17,294 | $22,061 | $39,466 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$39 | $0 | $0 | $0 |
| Operating Expenses | $71,562 | $42,197 | $69,171 | $127,018 |
| Operating Income | -$72,267 | -$34,304 | -$67,813 | -$127,018 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $639 | $1,667 | -$4,377 | -$1,914 |
| Pre-Tax Income | -$71,628 | -$32,637 | -$72,190 | -$128,932 |
| Tax Expense | $259 | -$212 | $438 | $133 |
| Net Income | -$71,887 | -$32,425 | -$72,628 | -$129,065 |
| % Margin | – | – | – | – |
| EPS | -0.98 | -0.62 | -2.93 | -8.02 |
| % Growth | -58.1% | 78.8% | 63.5% | – |
| EPS Diluted | -0.98 | -0.62 | -2.93 | -8.02 |
| Weighted Avg Shares Out | 73,212 | 52,181 | 24,813 | 16,101 |
| Weighted Avg Shares Out Dil | 73,212 | 52,181 | 24,813 | 16,101 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $27 | $799 | $4,377 | $7,530 |
| Depreciation & Amortization | $666 | $2,466 | $3,094 | $2,450 |
| EBITDA | -$70,935 | -$29,372 | $0 | -$118,952 |
| % Margin | – | – | – | – |